Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P21
Within normal range
vs 3Y Ago
-2.9x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2025-189.24%
2024-136.75%
202325.50%
202266.23%
2021-231.66%
2020-15.34%
2019-24.11%
201825.12%
201782.52%
2016-236.68%